Back to results
US 7,008,933 B2Granted
Process for prophylaxis and therapy of thrombotic processes employing heparin having particular average molecular weights
OwnerDieter Welzelinventor
Life of this patent
Estimating the term…
Abstract
A process for prophylaxis and therapy of thrombotic processes includes preparing heparin having an average molecular weight ranging from 10 to 11.5 kd; formulating a pharmaceutical preparation which includes the heparin; and employing the pharmaceutical preparation for prophylaxis and therapy of thrombotic processes. Preferably the heparin has an average molecular weight of 10.5 kd.
Claims4
A process for treatment of thrombo-embolic processes, comprising:
- administering an effective amount of a medium molecular weight heparin (MMWH) pharmaceutical preparation to a subject in need of treatment of thrombo-embolic processes, wherein the effective amount is sufficient to treat the thrombo-embolic processes and is characterized as having the higher therapeutic index of MMWH relative to low molecular weight heparin (LMWH) and unfractionated (UFH) and the MMWH has an average molecular weight ranging from 10 to 11.5 kDa.
Dependencies are inferred from the claim text.